GE HealthCare Technologies (GEHC) Depreciation & Amortization (CF) (2022 - 2026)

GE HealthCare Technologies' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $78.0 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 18.18% year-over-year to $78.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $299.0 million (up 12.41% YoY) and the FY2025 annual result came in at $287.0 million, up 7.09% from the prior year.
• Depreciation & Amortization (CF) was $78.0 million for Q1 2026 at GE HealthCare Technologies, up from $74.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $78.0 million in Q1 2026 and bottomed at $56.0 million in Q1 2022.
• A 5-year average of $65.2 million and a median of $65.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) declined 2.94% — and 2026, when it grew 18.18%.
• GE HealthCare Technologies' Depreciation & Amortization (CF) stood at $59.0 million in 2022, then grew by 1.69% to $60.0 million in 2023, then increased by 8.33% to $65.0 million in 2024, then rose by 13.85% to $74.0 million in 2025, then advanced by 5.41% to $78.0 million in 2026.
• Business Quant data shows GEHC's Depreciation & Amortization (CF) at $78.0 million in Q1 2026, $74.0 million in Q4 2025, and $75.0 million in Q3 2025.